SOURCE: Endo Pharmaceuticals

October 23, 2007 12:22 ET

Endo Pharmaceuticals to Hold Conference Call on Third Quarter 2007 Financial Results

CHADDS FORD, PA--(Marketwire - October 23, 2007) - Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP), a market leader in pain management, will announce its financial results for the third quarter ended September 30, 2007 before the market opens on November 1, 2007, and will hold a conference call at 11:00 a.m. ET that day to discuss those results.

Peter A. Lankau, President and Chief Executive Officer, Charles A. Rowland, Jr., Executive Vice President and Chief Financial Officer, and David A. Lee, Executive Vice President and Chief Scientific Officer, will participate in the call.

Investors and other interested parties may access the conference call as follows:

Telephone Numbers

(888) 713-4216 (domestic), (617) 213-4868 (international)

Passcode: 61517458

Please dial in 10 minutes prior to the scheduled start time.


A replay of the call will be available from November 1, 2007 at 1:00 p.m. ET by dialing (888) 286-8010 (domestic) or (617) 801-6888 (international), passcode 32593761, and will run until 12:00 a.m. ET on November 8, 2007.


A simultaneous webcast of the call for interested investors and others may be accessed by visiting In addition, a replay of the webcast will be available until 12:00 a.m. ET on November 8, 2007. The replay can be accessed by clicking on "Events" in the Investor Relations section of the website.

About Endo

Endo Pharmaceuticals Holdings Inc. is a fully integrated specialty pharmaceutical company with market leadership in pain management products. Through its Endo Pharmaceuticals Inc. subsidiary, the company researches, develops, produces and markets a broad product offering of branded and generic pharmaceuticals, meeting the needs of healthcare professionals and consumers alike. More information, including this and past press releases issued by Endo Pharmaceuticals Holdings Inc., is available online at